BIOMAT Database Logo BIOMAT Database Logo

[Blood pressure lowering effect of prazosin in severe hypertension]. 1979

E Török, and V Bíró, and M Glavanov, and M Wagner

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Török, and V Bíró, and M Glavanov, and M Wagner
Prazosin in severe in hypertension effect on blood pressure, plasma renin activity and in hypertensive emergencies.
August 1977, The Medical journal of Australia,
E Török, and V Bíró, and M Glavanov, and M Wagner
[Lowering of blood pressure in hypertension].
December 1971, Deutsche medizinische Wochenschrift (1946),
E Török, and V Bíró, and M Glavanov, and M Wagner
Hypertension: Benefits of strict blood-pressure lowering in hypertension.
March 2016, Nature reviews. Cardiology,
E Török, and V Bíró, and M Glavanov, and M Wagner
Blood pressure lowering effect of respiratory enzymes in experimental renal hypertension.
January 1947, Proceedings. American Federation for Clinical Research,
E Török, and V Bíró, and M Glavanov, and M Wagner
The blood pressure lowering effects of intravenous versus intracerebroventricular prazosin in anaesthetised cats.
June 1978, European journal of pharmacology,
E Török, and V Bíró, and M Glavanov, and M Wagner
Hypertension: Cardiovascular benefits of lowering blood pressure.
April 2016, Nature reviews. Nephrology,
E Török, and V Bíró, and M Glavanov, and M Wagner
Effect of blood pressure lowering on coronary vasodilator reserve in arterial hypertension.
February 1994, Cardiovascular drugs and therapy,
E Török, and V Bíró, and M Glavanov, and M Wagner
Hypertension: Blood-pressure lowering in type 2 diabetes.
October 2016, Nature reviews. Cardiology,
E Török, and V Bíró, and M Glavanov, and M Wagner
[The effect of prazosin on blood pressure and lipid status in patients with arterial hypertension].
January 1985, Vojnosanitetski pregled,
E Török, and V Bíró, and M Glavanov, and M Wagner
[Pressure lowering effect of veriloid in essential hypertension].
September 1953, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!